Garnet Health, a New York-based healthcare provider, faces a proposed class action tied to patient privacy and the use of its MyChart patient portal between May 7, 2020 and August 10, 2023. MyChart is a widely used platform that lets patients view test results, communicate with clinicians, and manage appointments, but lawsuits increasingly scrutinize what happens to web and portal activity data behind the scenes—especially when tracking technologies (such as pixels, cookies, or analytics tools) are embedded on login or scheduling pages and may transmit information to third parties. The lawsuit was filed because plaintiffs alleged that patient portal-related data was improperly shared or disclosed, potentially without valid patient authorization, raising concerns that sensitive health-related information could be linked to an individual and used for analytics or advertising purposes. The settlement website indicates eligible class members may receive a $19.50 payment without proof, reflecting a common approach in privacy settlements where individual damages can be hard to quantify but the alleged conduct is significant because it tests how healthcare organizations handle digital tracking in patient-facing tools. Broader implications extend beyond Garnet Health: similar suits have been brought against hospitals and health systems nationwide over alleged “pixel tracking” on patient portals and hospital websites, often arguing that the resulting disclosures violate medical privacy duties and consumer protection laws. These disputes sit at the intersection of industry compliance and modern marketing/analytics practices, where providers must balance site performance and user experience with strict confidentiality expectations and regulatory frameworks like HIPAA (which limits disclosures of protected health information by covered entities and their business associates) and, in some states, additional health-data and privacy statutes that can impose parallel obligations even when HIPAA’s boundaries are contested in court.